Vivo Bio Tech Ltd appoints Bhavish Vijayvargiya as Company Secretary

1 min read     Updated on 24 Jun 2026, 06:58 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Vivo Bio Tech Ltd appointed Bhavish Vijayvargiya as Company Secretary and Compliance Officer effective June 24, 2026, following the resignation of Mr. A V Kiran. The Board approved the appointment pursuant to Section 203 of the Companies Act 2013 and SEBI regulations. Mr. Vijayvargiya has been authorised to determine materiality of events and advise on disclosures.

powered bylight_fuzz_icon
43846796

*this image is generated using AI for illustrative purposes only.

Vivo Bio Tech Ltd appointed Bhavish Vijayvargiya as Company Secretary and Compliance Officer effective June 24, 2026, following the resignation of Mr. A V Kiran. The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee during a meeting held on June 24, 2026. Mr. A V Kiran resigned to pursue alternate career opportunities outside the organization and was relieved from his responsibilities with effect from June 24, 2026.

Mr. Bhavish Vijayvargiya has been designated as a Whole-Time Key Managerial Personnel (KMP) of the company. He is an Associate Member of the Institute of Company Secretaries of India, holding Membership No. A77631. His experience includes core areas of Corporate Secretarial functions and Compliance management.

The appointment was made pursuant to Section 203 of the Companies Act 2013 and Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosures were made in compliance with Regulation 30 read with Part A, Para A of Schedule III of the SEBI Regulations, 2015 and SEBI Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Details of Appointment and Resignation

The following table outlines the key details regarding the change in the Company Secretary and Compliance Officer position:

Details Resignation Appointment
Name Mr. A V Kiran Mr. Bhavish Vijayvargiya
Reason To pursue alternate career opportunities Appointment as Company Secretary and Compliance Officer
Effective Date June 24, 2026 June 24, 2026
Designation Company Secretary & Compliance Officer Company Secretary and Compliance Officer (Whole-Time KMP)

The Board has authorised Mr. Bhavish Vijayvargiya to determine the materiality of an event or information and for advising on disclosures to the stock exchanges. The contact details for the authorized person are provided below:

Name: Bhavish Vijayvargiya Designation: Company Secretary & Compliance Officer Address: 3rd Floor, Ilyas Mohammed Khan Estate#8-2-672/5 & 6, Road No. 1, Banjara Hills, Hyderabad, Telangana – 500034. Email: investor@vivobio.com Phone: 040-23313288

Historical Stock Returns for Vivo Bio Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.58%-4.33%-13.17%-28.26%-37.60%-74.52%

How will Mr. Vijayvargiya's expertise in compliance management influence Vivo Bio Tech's regulatory strategy in the upcoming fiscal year?

What specific corporate governance improvements can stakeholders expect following the appointment of a new Whole-Time Key Managerial Personnel?

Could the simultaneous resignation and appointment indicate a strategic shift in the company's leadership structure or operational focus?

Vivo Bio Tech seeks nod for ₹30 crore related party transactions

2 min read     Updated on 13 Jun 2026, 02:18 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Vivo Bio Tech has initiated a postal ballot process for shareholder approval on the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director and two related party transactions, including a ₹30 crore annual limit with Virinchi Limited. The company also seeks approval to appoint Mrs. Madhavi Latha Kompella as an Advisor for Strategy & Business Development. Remote e-voting is scheduled from June 15, 2026, to July 14, 2026, with the cut-off date for eligibility on June 05, 2026.

powered bylight_fuzz_icon
42789436

*this image is generated using AI for illustrative purposes only.

Vivo Bio Tech has initiated a postal ballot process seeking shareholder approval for the re-appointment of a Whole-time Director and two related party transactions, including a potential annual engagement worth ₹30 crore with Virinchi Limited. The company has scheduled remote e-voting from June 15, 2026, to July 14, 2026, to pass resolutions on these matters, which are critical for its strategic leadership and operational continuity.

The first resolution seeks the re-appointment of Mr. Kalyan Ram Mangipudi (DIN: 02012580) as Whole-time Director. His remuneration is proposed to be a consolidated salary of up to ₹1,00,000 per month, with the Board authorized to revise the gross salary by a maximum of 50% per annum. The company stated that the remuneration will comply with the limits under Sections 197 and 198 of the Companies Act, 2013, and Schedule V thereto.

Shareholders will also vote on appointing Mrs. Madhavi Latha Kompella, a Promoter, as an Advisor for Strategy & Business Development for a term of five years from October 01, 2026, to September 30, 2031. The appointment involves a fixed fee of ₹15,00,000 per month and reimbursement of actual expenses incurred for travel and lodging. The company noted that this transaction is material, representing approximately 3.37% of the annual consolidated turnover for FY 2025-26.

The third resolution requests approval for material related party transactions with Virinchi Limited, where Vivo Bio Tech holds a 5.38% stake. The company seeks approval to enter into transactions involving the availing of software consultancy services and the transfer of resources or inter-corporate loans. The aggregate value of these transactions shall not exceed ₹30,00,00,000 during a financial year. Inter-corporate loans, if any, will carry an interest rate of approximately 9% per annum and be repayable within 12 months.

The Board of Directors has appointed Mr. G. Vinay Babu, Practicing Company Secretary, as the Scrutinizer to ensure the voting process is conducted fairly. The results of the postal ballot will be declared on or before Thursday, July 16, 2026. The cut-off date for determining shareholder eligibility to vote is Friday, June 05, 2026.

Resolution Key Details
Re-appointment of Director Mr. Kalyan Ram Mangipudi; Salary up to ₹1,00,000/month
Advisor Appointment Mrs. Madhavi Latha Kompella; ₹15,00,000/month; 5 years
Transactions with Virinchi Limited Limit of ₹30 crore/year; Includes loans at 9% interest

The notice was dispatched to members on June 12, 2026. Advertisements pertaining to the Notice of Postal Ballot & E-Voting were published in the Financial Express and Nava Telangana on June 13, 2026. Shareholders can cast their votes electronically through the CDSL e-voting system during the designated window.

Historical Stock Returns for Vivo Bio Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-1.58%-4.33%-13.17%-28.26%-37.60%-74.52%

How will the proposed ₹30 crore annual engagement with Virinchi Limited impact Vivo Bio Tech's cash flow and liquidity position?

What strategic benefits does the company expect to justify the significant ₹1.8 crore annual expense for the Promoter's advisory role?

Will the re-appointment of Mr. Mangipudi drive any major shifts in the company's long-term growth strategy or operational focus?

More News on Vivo Bio Tech

1 Year Returns:-37.60%